-
MK-8745: Aurora A Inhibitor Workflows
2026-09-27
Use MK-8745 to probe Aurora A–dependent mitotic arrest, tetraploidy, and apoptosis, with dose and time-course designs that expose differences in p53 status. A recent retinoblastoma study strengthens the rationale for investigating AURKA in high-risk tumors, but does not establish MK-8745 as a validated retinoblastoma treatment.
-
SERCA-Linked ER Stress Promotes HSC Mobilization
2026-09-26
Li et al. report that inhibiting SERCA with BHQ promotes hematopoietic stem cell mobilization in mice, alongside reduced surface CXCR4 and changes in CaMKII–STAT3 signaling. The work connects endoplasmic-reticulum calcium handling with a pathway relevant to stem-cell retention, while leaving dose, timing, and clinical translation to be established in further studies.
-
MK-0812 for CCR2-Driven MASH Research
2026-09-26
Use MK-0812 to test whether CCR2-dependent monocyte trafficking contributes to inflammation downstream of gut–liver disruption—not as a stand-in for correcting the initiating intestinal defect. This workflow combines concentration-response assays, cell-trafficking readouts, and MASH model endpoints to separate those mechanisms.
-
β-Blocker Selectivity and HCT Engraftment
2026-09-25
A 2025 study links β-adrenergic receptor selectivity to blood-cell recovery after hematopoietic cell transplantation: nonselective blockade impaired regeneration in mice and was associated with delayed platelet engraftment and lower survival after allogeneic transplantation in patients. β1-selective metoprolol did not show the same pattern, highlighting a clinically relevant distinction that warrants further prospective study.
-
HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody
2026-09-25
A practical guide to using this Alexa Fluor 488-conjugated secondary antibody in human-IgG immunofluorescence, flow cytometry, Western blotting, and fluorescence ELISA workflows. It also explains how to relate these assays to preclinical SARS-CoV-2 vaccine research without mistaking animal immunoglobulin readouts for human-IgG detection.
-
Adiponectin Limits Splenectomy-Related Cognitive Deficits
2026-09-24
In aged male rats, adiponectin pretreatment improved learning and memory after splenectomy alongside reduced hippocampal inflammatory and oxidative-stress signals. Pharmacological inhibition and activation of TLR4 support involvement of the TLR4/MyD88/NF-κB pathway, although the findings are preclinical and do not establish a treatment for human perioperative neurocognitive disorder.
-
Palmitic acid (N2456): Practical Workflow Guide
2026-09-24
Palmitic acid, also called hexadecanoic acid, provides a defined saturated fatty-acid input for lipid metabolism, insulin signaling, and inflammation signaling studies. It is suitable for solvent-based workflows, but not aqueous stock preparation; prepare solutions for prompt use and do not store them long term.
-
1,2-Dioleoyl-sn-glycero-3-PE (DOPE) Workflow
2026-09-23
This guide explains how to handle 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) as a helper phospholipid for cationic liposomes and related lipid nanoparticle formulations. It covers solvent selection, fresh-solution preparation, formulation controls, and interpretation limits; DOPE should not be treated as a water-soluble or standalone transfection reagent.
-
MK-0812 CCR2 Inhibitor for MASH Research
2026-09-22
MK-0812 is a selective CCR2 antagonist for studying monocyte trafficking, MCP-1 signaling inhibition, and inflammatory recruitment. Product data report nanomolar functional activity in human and rhesus blood assays, while the MASH literature supports a testable gut–liver inflammation hypothesis rather than a proven therapeutic application.
-
JXE-23 Autophagy and Cell-Cycle Arrest in HCC
2026-09-22
The 2024 study of the fern-derived diterpene JXE-23 identifies selective cytotoxicity toward HepG2 hepatocellular carcinoma cells, with G2/M arrest, migration suppression, and protective autophagy linked to CIP2A/p-AKT/c-Myc signaling. Its strongest contribution is the mechanistic proposal that autophagy inhibition may enhance JXE-23 activity, while the findings remain limited to cellular models and require in vivo validation.
-
Intravesical p21 mRNA–LNP Therapy in Bladder Cancer
2026-09-21
The reference study develops chemically modified p21 mRNA in lipid nanoparticles as a localized tumor suppressor replacement strategy for bladder cancer. Its data connect bladder-restricted protein expression with cell-cycle inhibition, DNA-damage signaling, apoptosis, and reduced orthotopic tumor growth, while also identifying formulation and translational questions that require further study.
-
MK-0812: Decoding Monocyte–Gut–Liver Signals
2026-09-21
MK-0812 provides a selective CCR2 pharmacology tool for separating monocyte recruitment from upstream gut–liver pathology. This article translates the TM6SF2–MASH findings into a causal assay strategy rather than another routine dosing protocol.
-
DOPE Workflows for Nucleic Acid Delivery
2026-09-20
Learn how DOPE supports endosomal escape, cationic liposome design, and practical nucleic acid delivery workflows. The article also translates a rice blast lipidomics study into assay controls without overstating what DOPE can prove in fungal ferroptosis research.
-
Iron Stress Reprograms Enterocyte Metabolism
2026-09-19
Navazesh and Ji show that iron deficiency and iron excess produce distinct transcriptional and metabolic adaptations in IPEC-J2 enterocytes. Their combination of iron perturbation, inflammatory challenge, and untargeted metabolomics links iron availability to proliferation, glycolysis, lipid metabolism, antioxidant balance, and partial metabolic recovery after repletion.
-
Etoposide (VP-16) for Senescence and DNA Damage
2026-09-19
Use Etoposide (VP-16) as a controllable topoisomerase II stressor to connect DNA double-strand breaks with apoptosis, senescence, and high-content imaging. This workflow combines concentration benchmarking, orthogonal validation, and machine-learning-compatible phenotyping for cancer chemotherapy research.